DOSSIER · 13F-HR · Q2 2026

KVP Capital Advisors, LP

$136M in tracked AUM across 35 positions as of Q2 2026.

KC
CIK 0001858198 · last filed Jun 30, 2026
Total AUM
$136M
as of Q2 2026
Holdings
35
—
positions
Whale Score
54
54
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

KVP Capital Advisors, LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
PRAX
PRAXIS PRECISION MEDICINES I
$14M43K10.5%
02
WHWK
WHITEHAWK THERAPEUTICS INC
$10M2.2M7.3%
03
ERAS
ERASCA INC
$8M455K6.1%
04
TRVI
TREVI THERAPEUTICS INC
$8M414K5.7%
05
STRO
SUTRO BIOPHARMA INC
$8M227K5.5%
06
TNGX
TANGO THERAPEUTICS INC
$7M230K5.3%
07
MBX
MBX BIOSCIENCES INC
$7M122K4.9%
08
PTGX
PROTAGONIST THERAPEUTICS INC
$6M53K4.8%
09
EWTX
EDGEWISE THERAPEUTICS INC
$5M133K4.0%
10
TNDM
TANDEM DIABETES CARE INC
$5M301K3.3%

Filing history

2026Q2Jun 30
$136M▲ 1.7%
35 positionsView →
2026Q1Mar 31
$134M▲ 29.6%
32 positionsView →
2025Q4Dec 31
$103M—
27 positionsView →